ID

42250

Beschreibung

Study ID: 104864/410 Clinical Study ID: 104864/410 Study Title: A randomised open-label multicentre Phase II study to evaluate the safety and efficacy of intravenous topotecan given with either cisplatin or etoposide every 21 days as first-line therapy in patients with extensive-disease (ED) small-cell lung cancer Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Sponsor: GlaxoSmithKline Phase: Phase 2 Study Recruitment Status: Completed Generic Name: Topotecan Study Indication: Lung Cancer

Stichworte

Versionen (1)
  1. 18.04.21 18.04.21 -
Rechteinhaber

GlaxoSmithKline

Hochgeladen am

18. April 2021

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY 4.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Safety and efficacy of topotecan in patients with extensive-disease small-cell lung cancer (104864/410)

Englisch

Screening - Prior an Concomitant Medication; Telephone Randomisation

1 Formulare  
Administrative
Beschreibung

Administrative

Alias
UMLS CUI-1
C1320722
Patient Number
Beschreibung

Patient Number

Datentyp

text

Alias
UMLS CUI [1]
C2348585
Patient Initials
Beschreibung

Patient Initials

Datentyp

text

Alias
UMLS CUI [1]
C2986440
Prior and Concomitant Medication
Beschreibung

Prior and Concomitant Medication

Alias
UMLS CUI-1
C2826257
UMLS CUI-2
C2347852
Has the patient taken any medication in the past 30 years?
Beschreibung

If "Yes" please record details below. Where appropriate, medical conditions should be recorded in the Significant Medical/ Surgical History and Physical examination section, utilising the same terminology. Record PM for prophylactic treatment with the Medical Condition for prophylactically administered medications.

Datentyp

boolean

Alias
UMLS CUI [1]
C2826257
Prior and Concomitant Medication
Beschreibung

Prior and Concomitant Medication

Alias
UMLS CUI-1
C2826257
UMLS CUI-2
C2347852
Drug Name
Beschreibung

Trade Name preferred

Datentyp

text

Alias
UMLS CUI [1]
C0013227
Total Daily Dose
Beschreibung

Total Daily Dose

Datentyp

text

Alias
UMLS CUI [1,1]
C2348070
UMLS CUI [1,2]
C0013227
Administration Route
Beschreibung

Administration Route

Datentyp

text

Alias
UMLS CUI [1]
C0013153
Medical Condition
Beschreibung

Medical Condition

Datentyp

text

Alias
UMLS CUI [1]
C0012634
Medication Start Date
Beschreibung

Medication Start Date

Datentyp

date

Alias
UMLS CUI [1]
C2826734
Medication End Date
Beschreibung

Medication End Date

Datentyp

date

Alias
UMLS CUI [1]
C2826744
Medication Continuing
Beschreibung

Medication Continuing

Datentyp

integer

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0549178
Telephone Randomisation
Beschreibung

Telephone Randomisation

Alias
UMLS CUI-1
C0039457
UMLS CUI-2
C0034656
Has the patient been registered and randomised using the centralised telephone system?
Beschreibung

If "Yes" please record the patient's randomisation number

Datentyp

boolean

Alias
UMLS CUI [1]
C1514821
UMLS CUI [2]
C0034656
UMLS CUI [3]
C0039457
Randomisation Number
Beschreibung

Randomisation Number

Datentyp

text

Alias
UMLS CUI [1,1]
C0034656
UMLS CUI [1,2]
C0237753
Patient's randomised treatment arm
Beschreibung

Patient's randomised treatment arm

Datentyp

text

Alias
UMLS CUI [1]
C1522541
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Screening - Prior an Concomitant Medication; Telephone Randomisation

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
Administrative
C1320722 (UMLS CUI-1)
Patient Number
Item
Patient Number
text
C2348585 (UMLS CUI [1])
Patient Initials
Item
Patient Initials
text
C2986440 (UMLS CUI [1])
Item Group
Prior and Concomitant Medication
C2826257 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
Has the patient taken any medication in the past 30 years?
Item
Has the patient taken any medication in the past 30 years?
boolean
C2826257 (UMLS CUI [1])
Item Group
Prior and Concomitant Medication
C2826257 (UMLS CUI-1)
C2347852 (UMLS CUI-2)
Drug Name
Item
Drug Name
text
C0013227 (UMLS CUI [1])
Total Daily Dose
Item
Total Daily Dose
text
C2348070 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
Administration Route
Item
Administration Route
text
C0013153 (UMLS CUI [1])
Medical Condition
Item
Medical Condition
text
C0012634 (UMLS CUI [1])
Medication Start Date
Item
Medication Start Date
date
C2826734 (UMLS CUI [1])
Medication End Date
Item
Medication End Date
date
C2826744 (UMLS CUI [1])
Item
Medication Continuing
integer
C0013227 (UMLS CUI [1,1])
C0549178 (UMLS CUI [1,2])
Medication Continuing
Code List
Medication Continuing
CL Item
Medication Continuing (1)
Item Group
Telephone Randomisation
C0039457 (UMLS CUI-1)
C0034656 (UMLS CUI-2)
Has the patient been registered and randomised using the centralised telephone system?
Item
Has the patient been registered and randomised using the centralised telephone system?
boolean
C1514821 (UMLS CUI [1])
C0034656 (UMLS CUI [2])
C0039457 (UMLS CUI [3])
Randomisation Number
Item
Randomisation Number
text
C0034656 (UMLS CUI [1,1])
C0237753 (UMLS CUI [1,2])
Item
Patient's randomised treatment arm
text
C1522541 (UMLS CUI [1])
Patient's randomised treatment arm
Code List
Patient's randomised treatment arm
CL Item
Regimen 1 - Topotecan for 5 Days and Cisplatin on Day 5 (TC)
CL Item
Regimen 2 - Topotecan for 5 Days and Etoposide for 5 Days (TE)
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video